Just 60 days after submitting its application, <B>Spectranetics</B> (Colorado Springs, Colorado) last month received FDA clearance for its Turbo-Booster product treatment of arterial stenoses and occlusions in the leg, a broader indication for use as compared to current labeling of the existing peripheral laser catheters, the company said.